DNA Polyplexes of a Phosphorylcholine-Based Zwitterionic Polymer for Gene Delivery

Area of Science:

• Biomaterials Science
• Gene Therapy
• Nanotechnology

Background:

• Glioblastoma multiforme (GBM) is an aggressive brain tumor with limited treatment options.
• Effective gene delivery systems are crucial for developing novel GBM therapies.
• Polyplexes offer a promising platform for delivering therapeutic nucleic acids.

Purpose of the Study:

• To evaluate the potential of PMPC-DB polyplexes for delivering plasmid DNA (pDNA) to glioblastoma cells.
• To characterize the physicochemical properties of PMPC-DB/pDNA polyplexes.
• To assess the safety and efficacy of these polyplexes in vitro.

Main Methods:

• Synthesized and characterized PMPC-DB diblock copolymers.
• Formed polyplexes with plasmid DNA (pDNA).
• Assessed polyplex physicochemical properties (size, zeta potential).
• Evaluated cytocompatibility using ATP assays with U-87MG and U-138MG cells.
• Measured transfection efficiency using luciferase reporter gene assays.
• Determined anti-proliferative, apoptotic, and cell migration inhibitory effects of PMPC-DB/Interferon-beta (IFN-β1) polyplexes.

Main Results:

• PMPC-DB copolymer successfully condensed pDNA into nanosized polyplexes (100-150 nm) with narrow polydispersity and near-neutral surface charge.
• PMPC-DB/Luciferase pDNA polyplexes demonstrated safety and an 18-fold increase in luciferase expression compared to PEI polyplexes in U-87MG cells.
• PMPC-DB/IFN-β1 polyplexes exhibited significant anti-proliferative, apoptosis-inducing, and cell migration inhibitory effects in glioblastoma cells.

Conclusions:

• PMPC-DB/DNA polyplexes represent a safe and effective gene delivery system for glioblastoma.
• The developed polyplexes show potential for further optimization and in vivo studies.
• This study provides a foundation for advancing PMPC-DB based gene therapy strategies for brain tumors.